GIANAKAKOS ANASTASIOS 4
4 · LianBio · Filed Jan 3, 2022
Insider Transaction Report
Form 4
LianBioLIAN
GIANAKAKOS ANASTASIOS
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2021-12-29$6.49/sh+36,548$237,197→ 36,548 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-29−36,548→ 109,647 totalExercise: $6.49Exp: 2030-12-17→ Ordinary Shares (36,548 underlying)
Holdings
- 309,623(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]25% of the shares underlying the option vested and became exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.